JP2016511767A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016511767A5 JP2016511767A5 JP2015558553A JP2015558553A JP2016511767A5 JP 2016511767 A5 JP2016511767 A5 JP 2016511767A5 JP 2015558553 A JP2015558553 A JP 2015558553A JP 2015558553 A JP2015558553 A JP 2015558553A JP 2016511767 A5 JP2016511767 A5 JP 2016511767A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- naaladl2
- pharmaceutical composition
- antibody
- affinity reagent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1303308.9A GB201303308D0 (en) | 2013-02-25 | 2013-02-25 | Therapeutic and diagnostic target |
| GB1303308.9 | 2013-02-25 | ||
| PCT/GB2014/050549 WO2014128504A1 (en) | 2013-02-25 | 2014-02-24 | Inactive n-acetylated-alpha-linked acidic dipeptidase-like protein 2 (naaladl2) as a therapeutic and diagnostic target |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019033646A Division JP2019108354A (ja) | 2013-02-25 | 2019-02-27 | 治療的及び診断的標的としての不活性Ｎ−アセチル化−α−結合型酸性ジペプチダーゼ−様タンパク質２（ＮＡＡＬＡＤＬ２） |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016511767A JP2016511767A (ja) | 2016-04-21 |
| JP2016511767A5 true JP2016511767A5 (enExample) | 2017-03-30 |
| JP6523968B2 JP6523968B2 (ja) | 2019-06-05 |
Family
ID=48092041
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015558553A Active JP6523968B2 (ja) | 2013-02-25 | 2014-02-24 | 治療的及び診断的標的としての不活性Ｎ−アセチル化−α−結合型酸性ジペプチダーゼ−様タンパク質２（ＮＡＡＬＡＤＬ２） |
| JP2019033646A Pending JP2019108354A (ja) | 2013-02-25 | 2019-02-27 | 治療的及び診断的標的としての不活性Ｎ−アセチル化−α−結合型酸性ジペプチダーゼ−様タンパク質２（ＮＡＡＬＡＤＬ２） |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019033646A Pending JP2019108354A (ja) | 2013-02-25 | 2019-02-27 | 治療的及び診断的標的としての不活性Ｎ−アセチル化−α−結合型酸性ジペプチダーゼ−様タンパク質２（ＮＡＡＬＡＤＬ２） |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20160002351A1 (enExample) |
| EP (1) | EP2958590B1 (enExample) |
| JP (2) | JP6523968B2 (enExample) |
| DK (1) | DK2958590T3 (enExample) |
| ES (1) | ES2868998T3 (enExample) |
| GB (1) | GB201303308D0 (enExample) |
| WO (1) | WO2014128504A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013296557B2 (en) | 2012-07-31 | 2019-04-18 | Bioasis Technologies Inc. | Dephosphorylated lysosomal storage disease proteins and methods of use thereof |
| CN105263958B (zh) | 2013-03-13 | 2019-09-27 | 比奥阿赛斯技术有限公司 | p97片段及其应用 |
| US20190022244A1 (en) * | 2016-01-13 | 2019-01-24 | Bioasis Technologies, Inc. | Blood-brain barrier vector compounds and conjugates thereof |
| US20240177987A1 (en) * | 2021-03-25 | 2024-05-30 | Dh Technologies Development Pte. Ltd. | Method for Analyzing Samples Including a High M/Z Cutoff |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2150262C (en) * | 1992-12-04 | 2008-07-08 | Kaspar-Philipp Holliger | Multivalent and multispecific binding proteins, their manufacture and use |
| WO2005040402A2 (en) * | 2003-10-21 | 2005-05-06 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with n-acetylated alpha-linked acidic dipeptidase 2 (naaladase 2) |
| EP2195425A4 (en) * | 2007-08-24 | 2011-01-19 | Oncotherapy Science Inc | PKIB AND NAALADL2 FOR TARGET GENES OF THERAPY AND DIAGNOSIS OF PROSTATE CANCER |
| TWI653333B (zh) * | 2010-04-01 | 2019-03-11 | 安進研究（慕尼黑）有限責任公司 | 跨物種專一性之ＰＳＭＡｘＣＤ３雙專一性單鏈抗體 |
-
2013
- 2013-02-25 GB GBGB1303308.9A patent/GB201303308D0/en not_active Ceased
-
2014
- 2014-02-24 JP JP2015558553A patent/JP6523968B2/ja active Active
- 2014-02-24 WO PCT/GB2014/050549 patent/WO2014128504A1/en not_active Ceased
- 2014-02-24 US US14/769,980 patent/US20160002351A1/en not_active Abandoned
- 2014-02-24 DK DK14709738.0T patent/DK2958590T3/da active
- 2014-02-24 ES ES14709738T patent/ES2868998T3/es active Active
- 2014-02-24 EP EP14709738.0A patent/EP2958590B1/en active Active
-
2019
- 2019-02-27 JP JP2019033646A patent/JP2019108354A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011509079A5 (enExample) | ||
| JP5718319B2 (ja) | Ｈｅｒ２標的化療法に対する乳癌細胞の感受性を決定するためのバイオマーカー | |
| JP2016513094A5 (enExample) | ||
| FI3332006T3 (fi) | Uusia anti-PD-L1-vasta-aineita | |
| JP2008538289A5 (enExample) | ||
| JP2016536330A5 (enExample) | ||
| JP2015533788A5 (enExample) | ||
| JP2017518366A5 (enExample) | ||
| RU2017132214A (ru) | Анти-pvrig антитела и способы применения | |
| RU2018112516A (ru) | Метод | |
| WO2015084808A4 (en) | Identification of predictive biomarkers associated with wnt pathway inhibitors | |
| JP2016533395A5 (enExample) | ||
| EA202091810A1 (ru) | Антитела к b7-h4 и способы их применения | |
| NZ707116A (en) | Ly75 as cancer therapeutic and diagnostic target | |
| HRP20192347T1 (hr) | Antitijela prema klaudinu 18.2 koja su korisna u dijagnozi tumora | |
| SI2731972T1 (en) | Anti-folate receptor alpha antibodies and uses thereof | |
| HRP20210888T1 (hr) | Vezujuće molekule specifične za cd73 i njihova upotreba | |
| JP2013506428A5 (enExample) | ||
| JP2016539083A5 (enExample) | ||
| JP2013520174A5 (enExample) | ||
| JP2015531768A5 (enExample) | ||
| RU2016144178A (ru) | Антитело против muc1 или его антигенсвязывающий фрагмент и его применение | |
| JP2016511767A5 (enExample) | ||
| JP2010535506A5 (enExample) | ||
| JP2016500659A5 (enExample) |